111, Inc. (NASDAQ:YI) Sees Significant Decline in Short Interest

111, Inc. (NASDAQ:YI) saw a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 15,200 shares, a decline of 49.0% from the March 31st total of 29,800 shares. Based on an average trading volume of 65,600 shares, the short-interest ratio is currently 0.2 days.

Hedge Funds Weigh In On 111

An institutional investor recently bought a new position in 111 stock. Tower Research Capital LLC TRC bought a new position in shares of 111, Inc. (NASDAQ:YI) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 18,558 shares of the company’s stock, valued at approximately $29,000. 21.32% of the stock is owned by institutional investors.

111 Stock Up 2.0 %

YI stock opened at $1.03 on Friday. The company has a market cap of $86.03 million, a price-to-earnings ratio of -1.56 and a beta of 0.38. The business has a fifty day simple moving average of $1.24 and a 200-day simple moving average of $1.63. 111 has a 52 week low of $0.97 and a 52 week high of $3.36.

111 (NASDAQ:YI) last posted its quarterly earnings data on Thursday, March 21st. The company reported ($0.34) earnings per share for the quarter. The business had revenue of $578.69 million for the quarter.

111 Company Profile

111, Inc, together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.